Targeting breast cancer stem cells directly to treat refractory breast cancer

被引：6

作者：

Pan, Liping ^{[1
]}

Han, Juan ^{[2
]}

Lin, Ming ^{[2
]}

机构：

[1] Wuhan Ctr Clin Lab, Wuhan, Peoples R China

[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2023年 / 13卷

关键词：

breast cancer; immunotherapy; cancer stem cells; immunoresistance; oncology; REGULATORY T-CELLS; MISMATCH REPAIR-DEFICIENT; LUNG-CANCER; OPEN-LABEL; NEOADJUVANT CHEMOTHERAPY; CTLA-4; BLOCKADE; MOUSE MODEL; EXPRESSION; ANTIBODY; MULTICENTER;

D O I：

10.3389/fonc.2023.981247

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

For patients with refractory breast cancer (BC), integrative immunotherapies are emerging as a critical component of treatment. However, many patients remain unresponsive to treatment or relapse after a period. Different cells and mediators in the tumor microenvironment (TME) play important roles in the progression of BC, and cancer stem cells (CSCs) are deemed the main cause of relapse. Their characteristics depend on their interactions with their microenvironment as well as on the inducing factors and elements in this environment. Strategies to modulate the immune system in the TME of BC that are aimed at reversing the suppressive networks within it and eradicating residual CSCs are, thus, essential for improving the current therapeutic efficacy of BC. This review focuses on the development of immunoresistance in BCs and discusses the strategies that can modulate the immune system and target breast CSCs directly to treat BC including immunotherapy with immune checkpoint blockades.

引用

页数：9

共 87 条

[1]

[Anonymous], 2014, J Clin Oncol abstr, V32, p5s

[2]

[Anonymous], 2015, J IMMUNOTHERAPY CANC, DOI DOI 10.1186/2051-1426-3-S2-P152

[3] Xihuang pills, a traditional chinese preparation used as a complementary medicine to treat cancer: An updated review [J].

Bailly, Christian .

WORLD JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2020, 6 (02) :152-162

[4] Comprehensive molecular characterization of gastric adenocarcinoma [J].

Bass, Adam J. ;

Thorsson, Vesteinn ;

Shmulevich, Ilya ;

Reynolds, Sheila M. ;

Miller, Michael ;

Bernard, Brady ;

Hinoue, Toshinori ;

Laird, Peter W. ;

Curtis, Christina ;

Shen, Hui ;

Weisenberger, Daniel J. ;

Schultz, Nikolaus ;

Shen, Ronglai ;

Weinhold, Nils ;

Keiser, David P. ;

Bowlby, Reanne ;

Sipahimalani, Payal ;

Cherniack, Andrew D. ;

Getz, Gad ;

Liu, Yingchun ;

Noble, Michael S. ;

Pedamallu, Chandra ;

Sougnez, Carrie ;

Taylor-Weiner, Amaro ;

Akbani, Rehan ;

Lee, Ju-Seog ;

Liu, Wenbin ;

Mills, Gordon B. ;

Yang, Da ;

Zhang, Wei ;

Pantazi, Angeliki ;

Parfenov, Michael ;

Gulley, Margaret ;

Piazuelo, M. Blanca ;

Schneider, Barbara G. ;

Kim, Jihun ;

Boussioutas, Alex ;

Sheth, Margi ;

Demchok, John A. ;

Rabkin, Charles S. ;

Willis, Joseph E. ;

Ng, Sam ;

Garman, Katherine ;

Beer, David G. ;

Pennathur, Arjun ;

Raphael, Benjamin J. ;

Wu, Hsin-Ta ;

Odze, Robert ;

Kim, Hark K. ;

Bowen, Jay .

NATURE, 2014, 513 (7517) :202-209

[5] Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg [J].

Baur, Andreas S. ;

Lutz, Manfred B. ;

Schierer, Stephan ;

Beltrame, Luca ;

Theiner, Gabi ;

Zinser, Elisabeth ;

Ostalecki, Christian ;

Heidkamp, Gordon ;

Haendle, Ina ;

Erdmann, Michael ;

Wiesinger, Manuel ;

Leisgang, Waltraud ;

Gross, Stefanie ;

Pommer, Ansgar J. ;

Kaempgen, Eckhart ;

Dudziak, Diana ;

Steinkasserer, Alexander ;

Cavalieri, Duccio ;

Schuler-Thurner, Beatrice ;

Schuler, Gerold .

BLOOD, 2013, 122 (13) :2185-2194

[6] Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche [J].

Chakrabarti, Rumela ;

Celia-Terrassa, Toni ;

Kumar, Sushil ;

Hang, Xiang ;

Wei, Yong ;

Choudhury, Abrar ;

Hwang, Julie ;

Peng, Jia ;

Nixon, Briana ;

Grady, John J. ;

DeCoste, Christina ;

Gao, Jie ;

van Es, Johan H. ;

Li, Ming O. ;

Aifantis, Iannis ;

Clevers, Hans ;

Kang, Yibin .

SCIENCE, 2018, 360 (6396) :1421-+

[7] Combination Therapy with Anti-CTLA-4 and Anti-PD-1 Leads to Distinct Immunologic Changes In Vivo [J].

Das, Rituparna ;

Verma, Rakesh ;

Sznol, Mario ;

Boddupalli, Chandra Sekhar ;

Gettinger, Scott N. ;

Kluger, Harriet ;

Callahan, Margaret ;

Wolchok, Jedd D. ;

Halaban, Ruth ;

Dhodapkar, Madhav V. ;

Dhodapkar, Kavita M. .

JOURNAL OF IMMUNOLOGY, 2015, 194 (03) :950-959

[8] Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency [J].

Davies, Helen ;

Morganella, Sandro ;

Purdie, Colin A. ;

Jang, Se Jin ;

Borgen, Elin ;

Russnes, Hege ;

Glodzik, Dominik ;

Zou, Xueqing ;

Viari, Alain ;

Richardson, Andrea L. ;

Borresen-Dale, Anne-Lise ;

Thompson, Alastair ;

Eyfjord, Jorunn E. ;

Kong, Gu ;

Stratton, Michael R. ;

Nik-Zainal, Serena .

CANCER RESEARCH, 2017, 77 (18) :4755-4762

[9]

Demaria S, 2005, CLIN CANCER RES, V11, P728

[10] Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy [J].

Denkert, Carsten ;

von Minckwitz, Gunter ;

Darb-Esfahani, Silvia ;

Lederer, Bianca ;

Heppner, Barbara I. ;

Weber, Karsten E. ;

Budczies, Jan ;

Huober, Jens ;

Klauschen, Frederick ;

Furlanetto, Jenny ;

Schmitt, Wolfgang D. ;

Blohmer, Jens-Uwe ;

Karn, Thomas ;

Pfitzner, Berit M. ;

Kuemmel, Sherko ;

Engels, Knut ;

Schneeweiss, Andreas ;

Hartmann, Arndt ;

Noske, Aurelia ;

Fasching, Peter A. ;

Jackisch, Christian ;

van Mackelenbergh, Marion ;

Sinn, Peter ;

Schem, Christian ;

Hanusch, Claus ;

Untch, Michael ;

Loibl, Sibylle .

LANCET ONCOLOGY, 2018, 19 (01) :40-50

← 1 2 3 4 5 6 7 8 9 →